Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Pathway analysis of GWAS loci identifies novel drug targets and repurposing opportunities.

Jhamb D, Magid-Slav M, Hurle MR, Agarwal P.

Drug Discov Today. 2019 Jun;24(6):1232-1236. doi: 10.1016/j.drudis.2019.03.024. Epub 2019 Mar 29.

PMID:
30935985
2.

Longitudinal profiling of the lung microbiome in the AERIS study demonstrates repeatability of bacterial and eosinophilic COPD exacerbations.

Mayhew D, Devos N, Lambert C, Brown JR, Clarke SC, Kim VL, Magid-Slav M, Miller BE, Ostridge KK, Patel R, Sathe G, Simola DF, Staples KJ, Sung R, Tal-Singer R, Tuck AC, Van Horn S, Weynants V, Williams NP, Devaster JM, Wilkinson TMA; AERIS Study Group.

Thorax. 2018 May;73(5):422-430. doi: 10.1136/thoraxjnl-2017-210408. Epub 2018 Jan 31.

3.

Meta-analysis of human gene expression in response to Mycobacterium tuberculosis infection reveals potential therapeutic targets.

Wang Z, Arat S, Magid-Slav M, Brown JR.

BMC Syst Biol. 2018 Jan 10;12(1):3. doi: 10.1186/s12918-017-0524-z.

4.

Host response to respiratory bacterial pathogens as identified by integrated analysis of human gene expression data.

Smith SB, Magid-Slav M, Brown JR.

PLoS One. 2013 Sep 27;8(9):e75607. doi: 10.1371/journal.pone.0075607. eCollection 2013.

5.

Gastrointestinal weight-loss surgery: glimpses at the molecular level.

Freudenberg JM, Rajpal N, Way JM, Magid-Slav M, Rajpal DK.

Drug Discov Today. 2013 Jul;18(13-14):625-36. doi: 10.1016/j.drudis.2012.12.006. Epub 2012 Dec 21. Review.

PMID:
23266345
6.

Identification of common biological pathways and drug targets across multiple respiratory viruses based on human host gene expression analysis.

Smith SB, Dampier W, Tozeren A, Brown JR, Magid-Slav M.

PLoS One. 2012;7(3):e33174. doi: 10.1371/journal.pone.0033174. Epub 2012 Mar 14.

7.

Potential candidate genomic biomarkers of drug induced vascular injury in the rat.

Dalmas DA, Scicchitano MS, Mullins D, Hughes-Earle A, Tatsuoka K, Magid-Slav M, Frazier KS, Thomas HC.

Toxicol Appl Pharmacol. 2011 Dec 1;257(2):284-300. doi: 10.1016/j.taap.2011.09.015. Epub 2011 Sep 24.

PMID:
21983523
8.

Computational biology approaches for selecting host-pathogen drug targets.

Brown JR, Magid-Slav M, Sanseau P, Rajpal DK.

Drug Discov Today. 2011 Mar;16(5-6):229-36. doi: 10.1016/j.drudis.2011.01.008. Epub 2011 Jan 28. Review.

PMID:
21277381
9.

Effects of hepatic drug-metabolizing enzyme induction on clinical pathology parameters in animals and man.

Ennulat D, Walker D, Clemo F, Magid-Slav M, Ledieu D, Graham M, Botts S, Boone L.

Toxicol Pathol. 2010 Aug;38(5):810-28. doi: 10.1177/0192623310374332. Epub 2010 Jun 28.

PMID:
20585144
10.

Diagnostic performance of traditional hepatobiliary biomarkers of drug-induced liver injury in the rat.

Ennulat D, Magid-Slav M, Rehm S, Tatsuoka KS.

Toxicol Sci. 2010 Aug;116(2):397-412. doi: 10.1093/toxsci/kfq144. Epub 2010 May 13.

PMID:
20466777
11.

Molecular evolutionary analysis of cancer cell lines.

Zhang Y, Italia MJ, Auger KR, Halsey WS, Van Horn SF, Sathe GM, Magid-Slav M, Brown JR, Holbrook JD.

Mol Cancer Ther. 2010 Feb;9(2):279-91. doi: 10.1158/1535-7163.MCT-09-0508. Epub 2010 Feb 2.

12.

More than just innate immunity: comparative analysis of Chlamydophila pneumoniae and Chlamydia trachomatis effects on host-cell gene regulation.

Hess S, Peters J, Bartling G, Rheinheimer C, Hegde P, Magid-Slav M, Tal-Singer R, Klos A.

Cell Microbiol. 2003 Nov;5(11):785-95.

PMID:
14531894

Supplemental Content

Loading ...
Support Center